HER2-targeted therapy influences CTC status in metastatic breast cancer.
Deutsch TM, Riethdorf S, Fremd C, Feisst M, Nees J, Fischer C, Hartkopf AD, Pantel K, Trumpp A, Schütz F, Schneeweiss A, Wallwiener M.
Deutsch TM, et al. Among authors: fischer c.
Breast Cancer Res Treat. 2020 Jul;182(1):127-136. doi: 10.1007/s10549-020-05687-2. Epub 2020 May 20.
Breast Cancer Res Treat. 2020.
PMID: 32436146
Free PMC article.